Diane V Havlir MD
Professor, Medicine, University of California, San Francisco, School
Join to View Full Profile
995 Potrero AveBldg 80 Ward 84San Francisco, CA 94110
Phone+1 415-476-4082
Fax+1 415-502-2992
Dr. Havlir is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Infectious Disease, 1988 - 1990
University of California (San Francisco)Internship, Internal Medicine, 1984 - 1985
Duke University School of MedicineClass of 1984
Certifications & Licensure
CA State Medical License 1986 - 2027
OH State Medical License 1988 - 1990
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 21 citationsViral Suppression Rates at 48 Weeks in People With HIV Starting Long-Acting Cabotegravir/Rilpivirine With Initial Viremia.Matthew D Hickey, Nathanael Gistand, Janet Grochowski, Francis Mayorga-Munoz, Elizabeth Imbert
Clinical Infectious Diseases. 2025-04-30 - 2 citationsIncident Tuberculosis Infection Is Associated With Alcohol Use in Adults in Rural Uganda.Rachel Abbott, Kirsten Landsiedel, Mucunguzi Atukunda, Sarah B Puryear, Gabriel Chamie
Clinical Infectious Diseases. 2025-03-17 - 23 citationsDoxycycline Postexposure Prophylaxis and Sexually Transmitted Infection Trends.Madeline Sankaran, David V Glidden, Robert P Kohn, Trang Q Nguyen, Oliver Bacon
JAMA Internal Medicine. 2025-03-01
Journal Articles
- 'Safety and Impact of Low-Dose Methotrexate on Endothelial Function and InflammationSteven G Deeks, James H Stein, Carl Fichtenbaum, Judith S Currier, Priscilla, Clinical Infectious Diseases
- 'Dihydroartemisinin-Piperaquine for Intermittent Preventive Treatment of MalariaBryan Greenhouse, Prasanna Jagannathan, Diane V Havlir, PLoS One
Press Mentions
Ensitrelvir Reduced the Risk for COVID-19 by 67%March 12th, 2025- A Blueprint for More Equitable Care in Public Health CrisesDecember 7th, 2022
- Breakthrough COVID Research. Vital Health Care for Locals. And Now It Risks ClosureOctober 15th, 2022
Grant Support
- San Francisco Bay Clinical Trials Unit (CTU)PUBLIC HEALTH FOUNDATION ENTERPRISES2007–2027
- A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East AfricaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2026
- Training in HIV Translational ResearchUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2005–2026
- Strategic antiretroviral therapy and HIV testing for youth in rural AfricaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2018–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
